Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03777007 · ClinicalTrials.gov registry record · NA
A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement
A NA study of Total Joint Replacement Surgery, sponsored by Derek Amanatullah.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 1
- Study location
NCT03777007: Completed NA study of Total Joint Replacement Surgery, sponsored by Derek Amanatullah.
NCT03777007 is a NA study of Total Joint Replacement Surgery that has completed, run by Derek Amanatullah. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03777007, a NA study of Total Joint Replacement Surgery, has completed, sponsored by Derek Amanatullah.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 1
- Study location
Study Summary
SPARTA force plate is used as rehabilitation tool in this study. The device is Force Plate coupled with SPARTA scan software that enables quick assessment of individual movement and balance within minutes. The magnitude as well as efficiency of force production is analyzed to determine an patient recovery graph.
Primary Outcome
Length of stay will depend on the score generated by device.
Conditions Studied
Interventions
- DEVICE SPARTA force plate
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2019-08-26 |
| Est. Completion | 2022-04-19 |
| Phase | NA |
What the finished NCT03777007 record still lists
NCT03777007 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Total Joint Replacement Surgery appearing as the primary indexed condition, and to 1 intervention - of which SPARTA force plate is the first listed.
NCT03777007 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03777007 about?
NCT03777007 is a clinical study titled "A Rehabilitation Tool to Determine Patient's Stay in Hospital After Joint Replacement". SPARTA force plate is used as rehabilitation tool in this study. The device is Force Plate coupled with SPARTA scan software that enables quick assessment of individual movement and balance within minutes. The magnitude as well as efficiency of force production is analyzed to determine an patient re...
What is the current status of trial NCT03777007?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2019-08-26. Estimated completion is 2022-04-19.
What conditions does trial NCT03777007 study?
This clinical trial studies the following conditions: Total Joint Replacement Surgery.
What interventions are being tested in trial NCT03777007?
The interventions under investigation include: SPARTA force plate (DEVICE).
Who is sponsoring clinical trial NCT03777007?
This trial is sponsored by Derek Amanatullah, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03777007 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03777007's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI